Varona M A, Soriano A, Aguirre-Jaime A, Garrido S, Oton E, Diaz D, Portero J, Bravo P, Barrera M A, Perera A
Department of Surgery, Hospital Universitario Nuestra Sra. De Candelaria, S/C de Tenerife, Spain.
Department of Surgery, Hospital Universitario Nuestra Sra. De Candelaria, S/C de Tenerife, Spain.
Transplant Proc. 2015 Jan-Feb;47(1):84-9. doi: 10.1016/j.transproceed.2014.12.013.
Recurrence of hepatocellular carcinoma (HCC) and cirrhosis after a liver transplantation (LT) is a major concern, and a strict Milan criteria selection of candidates does not accurately discriminate the relapse rate after LT.
This study sought to analyze the risk factors affecting tumor recurrence after LT for related cirrhosis HCC and the application of the French prognostic model (preLT alpha-fetoprotein [AFP], size, number) in a single center.
In a retrospective observational study of LT for HCC and cirrhosis, clinicopathological features were analyzed. Also, the preoperative and postoperative AFP model score was calculated with a cutoff of 2.
Of 480, 109 patients underwent cadaveric LT for HCC. Eight of them had a relapse (7%). High AFP level, AFP model score >2, high pathological tumor-node-metastasis (pTNM) stage, poor differentiation, macrovascular-microvascular invasion, infiltration, and R1 margin were statistically significant (P < .05) for recurrence. Also, in the preoperative model, AFP score >2 was a predictor of worse survival (1-, 3-, 5-, 10-year survival of 81%, 51%, 30%, 30% vs 90%, 76%, 73%, 69% in ≤2, with P = .005). Regarding the postoperative model, similar results were found (1-, 3-, 5-, 10-year survival of 84%, 47%, 37%, 37% vs 90%, 78%, 73%, 52%, P = .028) between AFP model score >2 and ≤2, respectively. However, Milan and up-to-7 criteria were not accurate in recurrence nor in survival.
The French AFP model has proven to be a more discerning prognostic tool than other established criteria in the prediction of recurrence and survival. Also, in postoperative prognosis, pathological risk factors for relapse such as pTNM, differentiation grade, macrovascular-microvascular invasion, infiltration, and R1 margin have been predictors of recurrence.
肝移植(LT)后肝细胞癌(HCC)复发和肝硬化是主要关注点,严格按照米兰标准选择候选者并不能准确区分LT后的复发率。
本研究旨在分析影响相关肝硬化HCC患者LT后肿瘤复发的危险因素,以及法国预后模型(LT前甲胎蛋白[AFP]、肿瘤大小、肿瘤数量)在单中心的应用情况。
在一项针对HCC和肝硬化患者LT的回顾性观察研究中,分析临床病理特征。此外,计算术前和术后AFP模型评分,临界值为2。
480例患者中,109例因HCC接受尸体肝移植。其中8例复发(7%)。高AFP水平、AFP模型评分>2、高病理肿瘤-淋巴结-转移(pTNM)分期、低分化、大血管-微血管侵犯、浸润和R1切缘与复发具有统计学显著相关性(P <.05)。此外,在术前模型中,AFP评分>2是生存较差的预测因素(AFP评分>2组1年、3年、5年、10年生存率分别为81%、51%、30%、30%,AFP评分≤2组分别为90%、76%、73%、69%,P =.005)。在术后模型中,AFP模型评分>2组和≤2组也得到了类似结果(1年、3年、5年、10年生存率分别为84%、47%、37%、37%和90%、78%、73%、52%,P =.028)。然而,米兰标准和扩展至7标准在复发预测及生存预测方面均不准确。
在预测复发和生存方面,法国AFP模型已被证明是一种比其他既定标准更具辨别力的预后工具。此外,在术后预后方面,pTNM、分化程度、大血管-微血管侵犯、浸润和R1切缘等复发的病理危险因素是复发的预测因素。